tradingkey.logo
Markets
News
Analysis
Tools
Learn
Stock Score
Stock Score
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo

Apogee Therapeutics Inc

APGE
70.390USD
-0.530-0.75%
Close 11/26, 16:00（ET）Quotes delayed by 15 min
4.18BMarket Cap
LossP/E TTM

Apogee Therapeutics Inc

70.390
-0.530-0.75%
OverviewCompanyFinancialsAnalysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Apogee Therapeutics Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-27.59%-54.26M
-111.70%-62.03M
-53.23%-48.48M
-127.58%-67.71M
-113.90%-42.52M
-101.10%-29.30M
-199.67%-31.64M
---29.75M
---19.88M
---14.57M
---10.56M
--0.00
Net income from continuing operations
-32.65%-65.02M
-95.46%-66.10M
-72.43%-55.34M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
---31.73M
---20.84M
---18.89M
-190.94%-12.53M
---4.30M
Operating gains losses
745.83%406.00K
1008.33%399.00K
613.79%207.00K
--76.00K
--48.00K
--36.00K
--29.00K
----
----
----
----
----
Other non-cash items
78.19%-680.00K
69.60%-839.00K
37.73%-1.52M
19.15%-2.23M
-1243.97%-3.12M
---2.76M
---2.44M
---2.75M
---232.00K
----
-100.00%0.00
--1.69M
Change in working capital
-122.47%-837.00K
-543.39%-6.84M
-124.60%-2.95M
-336.16%-5.96M
1290.10%3.73M
-51.84%1.54M
-289.19%-1.31M
--2.52M
---313.00K
--3.20M
-73.48%694.00K
--2.62M
-Change in prepaid expenses
25.03%-2.11M
-109.15%-2.54M
161.22%895.00K
-196.60%-596.00K
-95.34%-2.81M
36.82%-1.21M
-3222.73%-1.46M
--617.00K
---1.44M
---1.92M
---44.00K
--0.00
-Change in other current assets
-293.48%-181.00K
-2165.67%-1.52M
---6.84M
114.95%16.00K
---46.00K
---67.00K
----
---107.00K
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
-27.59%-54.26M
-111.70%-62.03M
-53.23%-48.48M
-127.58%-67.71M
-113.90%-42.52M
-101.10%-29.30M
-199.67%-31.64M
---29.75M
---19.88M
---14.57M
---10.56M
--0.00
Investing cash flow
Net cash from continuing investing activities
-100.00%0.00
1405.88%768.00K
1129.91%4.32M
-100.60%-1.00K
--751.00K
--51.00K
--351.00K
--167.00K
----
----
----
----
Capital expenditures
-100.00%0.00
1405.88%768.00K
1129.91%4.32M
----
--751.00K
--51.00K
--351.00K
--167.00K
----
----
----
----
Net cash flow from disposal of fixed assets
-100.00%0.00
1405.88%768.00K
1129.91%4.32M
-100.60%-1.00K
--751.00K
--51.00K
--351.00K
--167.00K
----
----
----
----
Net cash flow from investment products
112.32%17.95M
153.07%78.89M
133.66%17.30M
217.31%46.37M
37.82%-145.63M
---148.66M
---51.39M
---39.52M
---234.22M
----
----
----
Net cash flow from other investing activities
--0.00
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
112.26%17.95M
152.54%78.13M
125.09%12.98M
216.82%46.37M
37.50%-146.38M
---148.71M
---51.74M
---39.69M
---234.22M
----
----
----
Financing cash flow
Cash flow from continuous financing activities
5053.52%19.74M
886.67%1.18M
-99.86%622.00K
20924.41%44.36M
-99.88%383.00K
91.15%-150.00K
--450.52M
---213.00K
--317.30M
---1.69M
-100.00%0.00
--5.00M
Net cash flow from common stock issuance/repurchase
--19.38M
100.00%0.00
-100.00%0.00
--43.53M
-100.00%0.00
---541.00K
--450.50M
----
--315.60M
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
--5.00M
Proceeds from stock option exercised by employees
-7.05%356.00K
201.79%1.18M
2491.67%622.00K
--828.00K
--383.00K
--391.00K
--24.00K
----
----
----
----
----
Net cash flow from other financing activities
--19.38M
----
----
----
----
----
----
----
--1.69M
---1.69M
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
5053.52%19.74M
886.67%1.18M
-99.86%622.00K
20924.41%44.36M
-99.88%383.00K
91.15%-150.00K
--450.52M
---213.00K
--317.30M
---1.69M
-100.00%0.00
--5.00M
Net cash flow
Beginning cash balance
-59.53%124.49M
-77.93%107.21M
19.79%142.08M
-36.75%119.07M
145.94%307.59M
243.69%485.75M
-21.91%118.61M
--188.27M
--125.07M
--141.33M
--151.89M
--0.00
Current period cash flow changes
91.21%-16.57M
109.70%17.28M
-109.50%-34.87M
133.03%23.01M
-398.29%-188.52M
-995.41%-178.16M
3577.70%367.14M
---69.66M
--63.20M
---16.26M
-311.14%-10.56M
--5.00M
Ending cash balance
-9.37%107.91M
-59.53%124.49M
-77.93%107.21M
19.79%142.08M
-36.75%119.07M
145.94%307.59M
243.69%485.75M
--118.61M
--188.27M
--125.07M
2726.66%141.33M
--5.00M
Free cash flow
-25.37%-54.26M
-113.95%-62.80M
-65.05%-52.79M
----
-117.68%-43.27M
---29.35M
---31.99M
---29.92M
---19.88M
----
----
----
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI